A wrist that snaps when you put a hand out on the stairs. A back that starts to curve. For many women, that is how they learn they have osteoporosis.
Osteoporosis
Osteoporosis means bones fragile enough to break easily, and it is silent until one does. Who is most at risk, how doctors check, and what the guidelines list.
The words and the guidance
- English
- Osteoporosis
- Also searched as
- brittle bones, thinning bones, osteopenia, DEXA scan, bone density scan
- Urdu
- ہڈیاں کمزور ہونا
- Roman Urdu
- haddiyan kamzor hona
- Women's Health Concern says postmenopausal women are by far the most common group with osteoporosis, and that the major loss of bone in women comes with the loss of estrogen at the menopause.
- NICE NG23 recommends that doctors "Give advice on bone health to people experiencing menopause and discuss bone health with them at review appointments" (1.2.4).
- The Pakistan Menopause Society's 2026 recommendations name an early age of menopause, endemic vitamin D deficiency, a high burden of osteoporosis and limited exercise among the challenges facing women in Pakistan (4.1).
- The same recommendations ask doctors to assess fracture risk and to consider a bone density (DXA) scan, where available, for women at high risk (Table 4).
What it is
Women's Health Concern, the patient arm of the British Menopause Society, describes osteoporosis as a thin bone disease that makes bones more fragile and more likely to break. Doctors call the breaks it causes fragility fractures.
The NHS website says it usually causes no pain until a bone breaks, and that broken bones in the spine can lead to a stooped, bent-forward posture.
Bone health covers what happens to bone in the years around the menopause.
Why it happens
Women's Health Concern says the major loss of bone in women comes with the loss of estrogen at the menopause. The NHS website adds that women are at greater risk if the menopause comes early, before 45, or if their ovaries have been removed.
The Pakistan Menopause Society describes the first five or six years after the final period as a time of accelerated bone loss (1.2.7.1). The British Menopause Society adds that South Asian women whose periods stop before 40 may not seek help, which it links to a higher risk of osteoporosis later.
Other risks the NHS names include taking high-dose steroid tablets for more than three months, a family history of osteoporosis (particularly a parent who broke a hip), heavy drinking and smoking.
What the guidance lists
How doctors check:
- History. The PMS recommendations ask doctors to record past fractures, loss of height, falls, steroid use and a family history of osteoporosis (Table 2).
- A risk score. The NHS website names online tools such as FRAX, which the PMS recommendations use to sort women into low, high and very high risk (6.4).
- A scan. The NHS describes a bone density scan, often called a DEXA or DXA scan, as a short, painless test that measures bone strength. The PMS recommendations suggest one, where available, for women at high risk: after a fragility fracture, with premature or early menopause, after long courses of steroids, with repeated falls or marked height loss (Table 4). In Pakistan, "where available" matters: a scan is not on offer everywhere.
What protects bone, in brief: the PMS recommendations call weight-bearing exercise such as walking essential for bone health, and list strength training alongside it (Table 6). The Menopause Society adds two cautions: exercise cannot reverse osteoporosis, and women who have it, especially after a spine fracture, should avoid lifting or pulling while bending forward or twisting. To prevent falls it names balance, walking and strength exercise such as tai chi, and cutting down, with a doctor, on medicines that make falls more likely, such as some sleeping tablets. For vitamin D and calcium, see vitamin D and calcium.
What the guidelines say about treatment
There are two kinds of medicine.
HRT is one. NICE NG23's table of benefits and risks says "Fragility fracture risk is decreased while taking HRT", and that the benefit holds during treatment and fades once it stops. The PMS recommendations list keeping bones healthy among the main reasons for MHT, their word for HRT (5.1). They also say MHT should not be the first-line treatment or prevention for osteoporosis in women aged 60 and over.
Non-hormonal medicines are the other. The PMS recommendations name several classes, among them bisphosphonates and denosumab, which slow bone loss, and medicines that help build new bone. NICE's osteoporosis guideline, NG259, asks doctors to consider treatment for women past the menopause by fracture risk, for example after a hip or spine fracture or with low bone density (1.7.3). Which medicine, for how long, and whether it suits your kidneys and heart is your doctor's decision with you.
One safety point comes from both The Menopause Society and the European Menopause and Andropause Society (EMAS): denosumab should not be stopped or delayed without another medicine to follow it, because bone can be lost quickly once it stops.
When to see a doctor
Ask about your bones if you have broken a bone in a minor fall, if you have lost height or noticed your back curving, or if your periods stopped before 45. Do not let a first break pass as bad luck: The Menopause Society names a past fracture as one of the strongest signs of another, with the risk highest in the two years after it.
NICE NG23 asks doctors to discuss bone health at menopause review appointments. If nobody has raised it, you can.
Questions to ask your doctor
- Given my age at menopause, my family history and any medicines I take, what is my risk of a fracture?
- Would a bone density scan be useful for me, where can I have one, and when should it be repeated?
- If my bones are thin, what are my treatment options, hormonal and non-hormonal?
- I have lost height, or broken a bone in a minor fall. Should that be checked?
- Which exercises are safe for my back, and could any of my medicines make me unsteady?
- If I stop HRT or denosumab, will my bones need another medicine?
Faith and family
The PMS recommendations name indoor lifestyle and purdah as reasons vitamin D matters so much in Pakistan (Table 5). Covering is a choice of faith, and nothing here asks you to change it. Do tell your doctor, though, because it changes which checks make sense.
A hip fracture in an older mother or grandmother often changes a whole household. If one happened in your family, mention it: family history is part of how risk is worked out.
Track it
- Roshara's symptom score rates 27 symptoms in a few minutes, with no account. The total is something to take to your appointment. Take the symptom score
- Where am I? names the stage you might be in. Six questions. Take Where am I?
- Log it day by day in the tracker, with what came just before. It needs a free account. Open the tracker
Common questions
- What does my T-score mean? Is osteopenia osteoporosis?
- The T-score from a bone density scan compares your bones with a healthy young adult's. The NHS website gives the bands: above -1 is normal, between -1 and -2.5 is osteopenia, and below -2.5 is osteoporosis. Osteopenia does not always lead to osteoporosis. EMAS uses the same bands, set by the World Health Organization. (Source: NHS website, Osteoporosis (reviewed 13 October 2022, review was due 13 October 2025))
- Is HRT a treatment for osteoporosis?
- NICE NG23 says fragility fracture risk is lower while taking HRT, and that the benefit fades once it stops. The Pakistan Menopause Society says HRT should not be used as the first-line treatment for osteoporosis in women aged 60 and over. The Menopause Society says non-hormone medicines are preferred for treating osteoporosis that is already there. (Source: Pakistan Menopause Society, Good Clinical Practice Recommendations for Menopause Care in Pakistan (JSOGP 16(2), 28 April 2026))
Sources
- Women's Health Concern, Osteoporosis: bone health following the menopause (factsheet, reviewed July 2026)Section: Introduction; Diagnosis · Opened 1 October 2026
- NHS website, Osteoporosis (reviewed 13 October 2022, review was due 13 October 2025)Section: Overview; Diagnosis · Opened 15 October 2026
- NHS website, Osteoporosis: causes (reviewed 13 October 2022, review was due 13 October 2025)Section: Who's at risk of osteoporosis: women · Opened 1 October 2026
- NICE NG23, Menopause: identification and management (last updated 15 April 2026)Section: 1.2.4; 1.6.2, Table 1 (osteoporosis) · Opened 1 October 2026© NICE 2026 Menopause: identification and management. Available from www.nice.org.uk/guidance/ng23 All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
- Pakistan Menopause Society, Good Clinical Practice Recommendations for Menopause Care in Pakistan (JSOGP 16(2), 28 April 2026)Section: 1.2.7.1; 4.1; Tables 1, 2, 4 and 6; 5.1; section 5 on MHT after 60; 6.4 · Opened 1 October 2026
- British Menopause Society, Tool for Clinicians: Menopause in ethnic minority women (published June 2023, review was due June 2026)Section: South Asian women · Opened 1 October 2026
- NICE NG259, Osteoporosis: risk assessment (published 29 July 2026)Section: 1.7.3 · Opened 10 October 2026
- The Menopause Society (then The North American Menopause Society), Management of osteoporosis in postmenopausal women: the 2021 position statement, Menopause 2021;28(9):973-997Section: Evaluating patients: key points; Physical activity and exercise; Fall prevention; Denosumab · Opened 15 October 2026
- The Menopause Society (then The North American Menopause Society), The 2022 hormone therapy position statement, Menopause 2022;29(7):767-794Section: Indications: prevention of bone loss · Opened 15 October 2026
- European Menopause and Andropause Society, Menopause Essentials 2026: Osteoporosis screening (July 2026)Section: The T-score · Opened 15 October 2026
- European Menopause and Andropause Society, Menopause Essentials 2026: Non-estrogen management of osteoporosis (July 2026)Section: Denosumab · Opened 15 October 2026